To hear about similar clinical trials, please enter your email below

Trial Title: Clinical, Histological and Prognostic Forms of Adenocarcinoma of the Anus

NCT ID: NCT05605873

Condition: Anal Adenocarcinoma

Conditions: Official terms:
Adenocarcinoma

Study type: Observational

Overall status: Unknown status

Study design:

Time perspective: Retrospective

Summary: Adenocarcinoma of the anus is rare. It concerns less than 10% of anal cancers and its incidence is less than 0.2/100 000 inhabitants. Its management is not consensual and is most often derived by analogy with that of adenocarcinoma of the lower rectum. This is due to the rarity but also to the diversity of anatomical (anal margin, anal canal, lower rectum), etiological (primary glandular tumors or secondary to anal fistula, primary distant tumor and/or Crohn's disease) and histological forms (mucinous, intestinal, glandular adenocarcinomas and primary or secondary Paget's disease). Most of the literature consists of small case series and simple clinical cases in which the prognosis of these subforms has not been studied.

Criteria for eligibility:

Study pop:
Patients with a diagnosis of adenocarcinoma of the anus between 01/01/2006 and 30/06/2022 in participating centers

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - Patient over 18 years of age - French-speaking patient - Patient with a diagnosis of adenocarcinoma of the anus between 01/01/2006 and 30/06/2022 in participating centers Exclusion Criteria: - Patient under guardianship or curatorship - Patient deprived of liberty - Patient under court protection - Patient objecting to the use of his data for this research

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Groupe Hospitalier Paris Saint-Joseph

Address:
City: Paris
Zip: 75014
Country: France

Facility:
Name: Centre hospitalo-universitaire de Cochin-Port Royal

Address:
City: Paris
Country: France

Start date: September 16, 2022

Completion date: December 31, 2023

Lead sponsor:
Agency: Fondation Hôpital Saint-Joseph
Agency class: Other

Source: Fondation Hôpital Saint-Joseph

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05605873

Login to your account

Did you forget your password?